Stacy Ann Coen - 09 Aug 2023 Form 4 Insider Report for ImmunoGen, Inc.

Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Aug 2023
Net transactions value
-$929,949
Form type
4
Filing time
11 Aug 2023, 17:02:31 UTC
Previous filing
04 Aug 2023
Next filing
11 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Options Exercise $493,033 +100,210 +914% $4.92 111,170 09 Aug 2023 Direct
transaction IMGN Common Stock Sale $1,422,982 -100,210 -90% $14.20 10,960 09 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (Right to Buy) Options Exercise $0 -100,210 -57% $0.000000 75,209 09 Aug 2023 Common Stock 100,210 $4.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.97 to $14.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
F2 Exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.